(Q45376156)

English

Fusion of C3d molecule with neutralization epitope(s) of hepatitis E virus enhances antibody avidity maturation and neutralizing activity following DNA immunization

scientific article published on 6 May 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Fusion of C3d molecule with neutralization epitope(s) of hepatitis E virus enhances antibody avidity maturation and neutralizing activity following DNA immunization (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

based on heuristic

inferred from title

hepatitis E virus

object named as

hepatitis E virus

1 reference

based on heuristic

inferred from title

author name string

Shucai Yang

1

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Chunling Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Xuefeng Fang

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Lijie Zhai

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Chen Dong

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Lei Ding

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Jihong Meng

7

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Lixin Wang

8

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

publication date

6 May 2010

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

151

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

162-169

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Genetic variability of hepatitis E virus within and between three epidemics in India

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Epidemiology of hepatitis E: current status

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Locally acquired hepatitis E virus infection, El Paso, Texas.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Complete nucleotide sequence of a hepatitis E virus isolated from the Xinjiang epidemic (1986–1988) of China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Sequence comparison of the capsid region of hepatitis E viruses isolated from Myanmar and China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

High Mortality Associated with an Outbreak of Hepatitis E among Displaced Persons in Darfur, Sudan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Identification of genotype 3 hepatitis E virus (HEV) in serum and fecal samples from pigs in Thailand and Mexico, where genotype 1 and 2 HEV strains are prevalent in the respective human populations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

C3d of complement as a molecular adjuvant: bridging innate and acquired immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Immunogenicity of candidate hepatitis E virus DNA vaccine expressing complete and truncated ORF2 in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

The first experimental study on a candidate combined vaccine against hepatitis A and hepatitis E.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

C3d enhancement of neutralizing antibodies to measles hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Seroepidemiology of hepatitis E virus in patients with non-A, non-B, non-C hepatitis in Hungary

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus (HEV).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

DNA vaccination against hepatitis E virus infection in cynomolgus macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Protective efficacy of hepatitis E virus DNA vaccine administered by gene gun in the cynomolgus macaque model of infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Aetiology, clinical course and outcome of sporadic acute viral hepatitis in pregnancy*

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Infection of a Japanese patient by genotype 4 hepatitis e virus while traveling in Vietnam.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Hepatitis E in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

The effect of antigen targeting sequences on antibody responses to hepatitis E virus DNA vaccines in rats and sheep

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Seroprevalence of hepatitis E virus infection, rural southern People's Republic of China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

A genotype IV hepatitis E virus strain that may be indigenous to Changchun, China.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Hepatitis E in the south west of France in individuals who have never visited an endemic area

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

High prevalence of anti-hepatitis E virus antibodies in blood donors from South West France

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Neutralization of different geographic strains of the hepatitis E virus with anti-hepatitis E virus-positive serum samples obtained from different sources

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Identification and characterization of the neutralization epitope(s) of the hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Possible risk factors for the transmission of hepatitis E virus and for the severe form of hepatitis E acquired locally in Hokkaido, Japan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Immunostimulant adjuvant patch enhances humoral and cellular immune responses to DNA immunization.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Identification of genotype 3 hepatitis E virus in fecal samples from a pig farm located in a Shanghai suburb

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Induction of antibody response against hepatitis E virus (HEV) with recombinant human papillomavirus pseudoviruses expressing truncated HEV capsid proteins in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

UK acquired hepatitis E--An emerging problem?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Hepatitis E outbreak on cruise ship.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Genetic heterogeneity of hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Characterization of Antibody Responses to Combinations of a Dengue Virus Type 2 DNA Vaccine and Two Dengue Virus Type 2 Protein Vaccines in Rhesus Macaques

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Overview of Hepatitis E Virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Identification of a genotype III swine hepatitis E virus that was isolated from a Japanese pig born in 1990 and that is most closely related to Japanese isolates of human hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Development and evaluation of an efficient cell-culture system for Hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Recombinant vaccine against hepatitis E: dose response and protection against heterologous challenge.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Contribution of C3d-P28 repeats to enhancement of immune responses against HBV-preS2/S induced by gene immunization

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Hepatitis E: an overview and recent advances in vaccine research.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Enhancement of humoral immunity to the hCG beta protein antigen by fusing a molecular adjuvant C3d3.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Detection of sporadic cases of hepatitis E virus (HEV) infection in China using immunoassays based on recombinant open reading frame 2 and 3 polypeptides from HEV genotype 4

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Prevalence of four different subgenotypes of genotype 4 hepatitis E virus among swine in the Shanghai area of China

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Hepatitis E virus genotyping based on full-length genome and partial genomic regions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Recombinant vaccine against hepatitis E: duration of protective immunity in rhesus macaques.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

Identification of two neutralization epitopes on the capsid protein of avian hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

A truncated ORF2 protein contains the most immunogenic site on ORF2: antibody responses to non-vaccine sequences following challenge of vaccinated and non-vaccinated macaques with hepatitis E virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

A new PCR-based seroneutralization assay in cell culture for diagnosis of hepatitis E

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies of the neutralizing activity and avidity of anti-human immunodeficiency virus type 1 Env antibody elicited by DNA priming and protein boosting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIRUSRES.2010.04.011

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VIRUSRES.2010.04.011

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45376156&oldid=2076250486"